Abstract:Small animal fluorescence molecular imaging (FMI) can be a powerful tool for preclinical drug discovery and development studies. However, light absorption by tissue chromophores (e.g., hemoglobin, water, lipids, melanin) typically limits optical signal propagation through thicknesses larger than a few millimeters. Compared to other visible wavelengths, tissue absorption for red and near-infrared (near-IR) light absorption dramatically decreases and non-elastic scattering becomes the dominant light-tissue interaction mechanism. The relatively recent development of fluorescent agents that absorb and emit light in the near-IR range (600-1000 nm), has driven the development of imaging systems and light propagation models that can achieve whole body three-dimensional imaging in small animals. Despite great strides in this area, the ill-posed nature of diffuse fluorescence tomography remains a significant problem for the stability, contrast recovery and spatial resolution of image reconstruction techniques and the optimal approach to FMI in small animals has yet to be agreed on. The majority of research groups have invested in charge-coupled device (CCD)-based systems that provide abundant tissue-sampling but suboptimal sensitivity, while our group and a few others have pursued systems based on very high sensitivity detectors, that at this time allow dense tissue sampling to be achieved only at the cost of low imaging throughput. Here we demonstrate the methodology for applying single-photon detection technology in a fluorescence tomography system to localize a cancerous brain lesion in a mouse model. The fluorescence tomography (FT) system employed single photon counting using photomultiplier tubes (PMT) and information-rich time-domain light detection in a non-contact conformation. This provides a simultaneous collection of transmitted excitation and emission light, and includes automatic fluorescence excitation exposure control, laser referencing, and co-registration with a small animal computed tomography (microCT) system. A nude mouse model was used for imaging. The animal was inoculated orthotopically with a human glioma cell line (U251) in the left cerebral hemisphere and imaged 2 weeks later. The tumor was made to fluoresce by injecting a fluorescent tracer, IRDye 800CW-EGF (LI-COR Biosciences, Lincoln, NE) targeted to epidermal growth factor receptor, a cell membrane protein known to be overexpressed in the U251 tumor line and many other cancers. A second, untargeted fluorescent tracer, Alexa Fluor 647 (Life Technologies, Grand Island, NY) was also injected to account for non-receptor mediated effects on the uptake of the targeted tracers to provide a means of quantifying tracer binding and receptor availability/density. A CT-guided, time-domain algorithm was used to reconstruct the location of both fluorescent tracers (i.e., the location of the tumor) in the mouse brain and their ability to localize the tumor was verified by contrast-enhanced magnetic resonance imaging. Though demonstrated for fluorescence imaging in a glioma mouse model, the methodology presented in this video can be extended to different tumor models in various small animal models potentially up to the size of a rat.

Multi-scale in vivo imaging of tumour development using a germline conditional triple-reporter system

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence

Bimodal positron-optical imaging of reporter gene expression and receptor targeting in mice

Optimized in vivo multispectral bioluminescent imaging of tumor biology using engineered BRET reporters

Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models

Imaging Transgenic Nude Mice Expressing Spectrally-distinct Fluorescent Reporters Emitting From Blue to Far Red Light With One Instrument With Single-nanometer-tuning of Laser-excitation Fluorescence

Correlative multiscale 3D imaging of mouse primary and metastatic tumors by sequential light sheet and confocal fluorescence microscopy

A bioluminescence reporter mouse strain for in vivo imaging of CD8+ T cell localization and function

Molecular Imaging of Small Animals with Fluorescent Proteins: from Projection to Multimodality

Non-Invasive Optical Imaging of Tumor Growth in Intact Animals

Use Of The Odd-Luciferase Transgene For The Non-Invasive Imaging Of Spontaneous Tumors In Mice

Multimodality reporter gene imaging: Construction strategies and application

Compact Whole-Body Fluorescent Imaging of Nude Mice Bearing Egfp Expressing Tumor

Application of MRI and Bioluminescence Dual Reporter Gene Imaging for in Vivo Monitoring of Tumor Growth

Non-Invasive In Vivo Imaging and Quantification of Tumor Growth and Metastasis in Rats Using Cells Expressing Far-Red Fluorescence Protein

Proof of concept of a multimodal intravital molecular imaging system for tumour transpathology investigation

Visualization of head and neck cancer models with a triple fusion reporter gene

In vivo long-term investigation of tumor bearing mKate2 by an in-house fluorescence molecular imaging system

Development of two mouse strains conditionally expressing bright luciferases with distinct emission spectra as new tools for in vivo imaging

Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers